Chardan Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO): "warrants a new look by investors" Mar 12, 2026 03:17PM
uniQure BV (QURE) PT Raised to $31 at Chardan Mar 9, 2026 01:04PM
EyePoint Inc. (EYPT) PT Raised to $29 at Chardan Mar 4, 2026 02:56PM
Chardan Reiterates Buy Rating on Arbutus Biopharma (ABUS) Following Moderna Settlement Mar 4, 2026 09:21AM
Chardan Reiterates Buy Rating on Dyne Therapeutics (DYN) Mar 2, 2026 05:37PM
View Older Stories

Mar 2, 2026 02:18PM Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan
Feb 24, 2026 07:39AM Chardan Capital Markets Upgrades Allurion Technologies (ALUR) to Buy
Feb 2, 2026 09:15AM VivoPower terminates at-the-market equity offering agreement
Jan 29, 2026 12:34AM Chardan Capital Markets Upgrades Korro Bio Inc. (KRRO) to Buy
Jan 23, 2026 06:44PM Aldabra 4 completes $300.15 million IPO on NASDAQ
Jan 21, 2026 08:25PM Aldabra 4 prices $261 million IPO at $10 per unit
Jan 21, 2026 04:15AM Chardan Capital Markets Starts Alumis Inc (ALMS) at Buy
Jan 20, 2026 09:00AM ZOOZ Reports Preliminary 2025 Financial Information, Cash and Bitcoin Positions and Additional Corporate Updates
Jan 20, 2026 07:27AM Chardan Capital Markets Starts ZOOZ Strategy (ZOOZ) at Buy
Jan 7, 2026 02:00PM Black Spade Acquisition III closes $172.5 million IPO on NYSE
Jan 7, 2026 02:00PM Black Spade Acquisition III Co Announces Closing of $172.5 Million Initial Public Offering, Including Full-Exercise of Over-Allotment Option
Jan 5, 2026 06:09PM Black Spade Acquisition III prices $150 million IPO
Jan 5, 2026 06:09PM Black Spade Acquisition III Co Announces Pricing of $150 Million Initial Public Offering
Jan 5, 2026 04:35AM Chardan Capital Markets Assumes Reviva Pharmaceuticals (RVPH) at Buy
Jan 5, 2026 04:34AM Chardan Capital Markets Assumes Stoke Therapeutics (STOK) at Buy
Jan 5, 2026 07:29AM Chardan Capital Markets Assumes Alto Neuroscience (ANRO) at Buy
Dec 31, 2025 04:09PM QumulusAI files for direct listing on Nasdaq
Dec 24, 2025 05:59AM Chardan Capital Markets Starts Hyperion DeFi, Inc. (HYPD) at Buy
Dec 24, 2025 06:00AM Chardan Capital Markets Starts Hyperliquid Strategies, Inc. (PURR) at Buy
Dec 23, 2025 04:42AM Chardan Capital Markets Starts Kalaris (KLRS) at Buy
Dec 23, 2025 04:41AM Chardan Capital Markets Starts Annexon Biosciences (ANNX) at Buy
Dec 18, 2025 01:17PM AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
Dec 16, 2025 03:50AM Palvella Therapeutics (PVLA) PT Raised to $174 at Chardan Capital Markets
Dec 4, 2025 09:00AM Lion Group raises $10 million, allocates $8 million for bitcoin purchase
Dec 4, 2025 09:00AM Lion Group Holding Ltd Announces $10 Million Private Placement for the acquisition of Bitcoin (BTC)
Dec 2, 2025 04:31PM Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics
Dec 2, 2025 04:30PM Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Nov 13, 2025 04:30PM Senti Bio reports Q3 financial results, confirms ASH data presentation
Nov 13, 2025 04:30PM Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual
Nov 13, 2025 03:05AM Chardan Capital Markets Downgrades Korro Bio Inc. (KRRO) to Neutral
Nov 10, 2025 07:30AM Corvex to merge with Movano in all-stock deal creating AI infrastructure firm
Nov 10, 2025 07:30AM CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
Nov 10, 2025 04:52AM Monopar Therapeutics (MNPR) PT Raised to $100 at Chardan Capital Markets
Nov 7, 2025 04:09AM Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral
Oct 31, 2025 08:00AM Alps Announces Closing of Business Combination with Globalink Investment Inc.
Oct 30, 2025 04:30AM Chardan Capital Markets Starts Kodiak AI (KDK) at Buy
Oct 28, 2025 03:24AM Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral
Oct 27, 2025 03:53AM Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral
Oct 20, 2025 06:21PM Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
Oct 20, 2025 06:21PM Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
Oct 16, 2025 09:05AM Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
Oct 16, 2025 09:05AM Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
Oct 16, 2025 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conference
Oct 16, 2025 07:53AM Chardan Capital Markets Starts Opus Genetics (IRD) at Buy
Oct 15, 2025 08:00AM Beacon Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference
Oct 15, 2025 07:05AM REGENXBIO to Participate in Upcoming Investor Conferences
Oct 14, 2025 04:01PM Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Oct 14, 2025 08:00AM 4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
Oct 14, 2025 08:00AM 4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
Oct 14, 2025 08:00AM Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
View Older Stories